Payment overview · 2025
General Payments
$22.98
1 reported records · 1 companies
Healthcare provider profile · identity verified
David Ross Freeman, MD
Allopathic & Osteopathic Physicians|General Practice · WILKINSBURG, PA · NPI 1770581142
Verified facts
What the public records show
CMS Open Payments records show David Ross Freeman, MD received $22.98 in general payments during 2025 across 1 reported records.
Gilead Sciences, Inc. accounted for 100.0% of that reported general-payment amount.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Gilead Sciences, Inc. | Unresolved — no canonical attribution shown | $22.98 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $22.98 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
Payment records were found, but the reported records did not identify a specific associated product for this analysis.
Public prescribing for products named in payments
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Amlodipine Besylate | Amlodipine Besylate | 407 | 77 |
| Gabapentin | Gabapentin | 362 | 51 |
| Atorvastatin Calcium | Atorvastatin Calcium | 329 | 65 |
| Omeprazole | Omeprazole | 282 | 43 |
| Hydrochlorothiazide | Hydrochlorothiazide | 177 | 28 |
| Pantoprazole Sodium | Pantoprazole Sodium | 142 | 27 |
| Trazodone Hcl | Trazodone Hcl | 138 | 21 |
| Lisinopril | Lisinopril | 134 | 25 |
| Levothyroxine Sodium | Levothyroxine Sodium | 127 | 24 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 126 | 25 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 122 | 33 |
| Fluticasone Propionate | Fluticasone Propionate | 120 | 27 |
| Oxycodone Hcl | Oxycodone Hcl | 106 | 20 |
| Tamsulosin Hcl | Tamsulosin Hcl | 106 | 17 |
| Metoprolol Tartrate | Metoprolol Tartrate | 105 | 14 |
| Furosemide | Furosemide | 88 | 18 |
| Metformin Hcl Er | Metformin Hcl | 88 | 17 |
| Mounjaro | Tirzepatide | 88 | 12 |
| Baclofen | Baclofen | 86 | 15 |
| Citalopram Hbr | Citalopram Hydrobromide | 86 | 14 |
| Zolpidem Tartrate | Zolpidem Tartrate | 86 | 11 |
| Allopurinol | Allopurinol | 81 | 15 |
| Metoprolol Succinate | Metoprolol Succinate | 81 | 16 |
| Tramadol Hcl | Tramadol Hcl | 81 | 15 |
| Meloxicam | Meloxicam | 79 | 20 |
| Pregabalin | Pregabalin | 78 | 11 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 78 | 19 |
| Losartan Potassium | Losartan Potassium | 77 | 22 |
| Carvedilol | Carvedilol | 73 | 16 |
| Ibuprofen | Ibuprofen | 73 | 16 |
| Metformin Hcl | Metformin Hcl | 73 | 18 |
| Clonazepam | Clonazepam | 71 | 11 |
| Prednisone | Prednisone | 71 | 35 |
| Eliquis | Apixaban | 70 | 15 |
| Alprazolam | Alprazolam | 65 | 11 |
| Sertraline Hcl | Sertraline Hcl | 64 | 12 |
| Jardiance | Empagliflozin | 63 | 12 |
| Buspirone Hcl | Buspirone Hcl | 62 | suppressed |
| Simvastatin | Simvastatin | 59 | 13 |
| Spironolactone | Spironolactone | 58 | 15 |
| Celecoxib | Celecoxib | 56 | suppressed |
| Potassium Chloride | Potassium Chloride | 53 | 13 |
| Atenolol | Atenolol | 50 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 49 | 11 |
| Duloxetine Hcl | Duloxetine Hcl | 45 | suppressed |
| Famotidine | Famotidine | 45 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 45 | suppressed |
| Bumetanide | Bumetanide | 44 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 44 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 43 | 14 |
| Escitalopram Oxalate | Escitalopram Oxalate | 41 | suppressed |
| Ozempic | Semaglutide | 41 | 11 |
| Montelukast Sodium | Montelukast Sodium | 39 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 39 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 38 | suppressed |
| Mirtazapine | Mirtazapine | 37 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 35 | 19 |
| Clopidogrel | Clopidogrel Bisulfate | 33 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 32 | suppressed |
| Sucralfate | Sucralfate | 31 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 31 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 30 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 29 | suppressed |
| Nifedipine Er | Nifedipine | 29 | suppressed |
| Xarelto | Rivaroxaban | 29 | suppressed |
| Hydrocortisone | Hydrocortisone | 27 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 27 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 26 | suppressed |
| Estradiol | Estradiol | 26 | suppressed |
| Metronidazole | Metronidazole | 26 | 12 |
| Olanzapine | Olanzapine | 26 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 26 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 26 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 25 | suppressed |
| Bupropion Xl | Bupropion Hcl | 24 | suppressed |
| Amoxicillin | Amoxicillin | 23 | 14 |
| Bupropion Hcl Sr | Bupropion Hcl | 23 | suppressed |
| Ondansetron Odt | Ondansetron | 23 | 13 |
| Pravastatin Sodium | Pravastatin Sodium | 23 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 22 | 16 |
| Clobetasol Propionate | Clobetasol Propionate | 22 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 22 | 21 |
| Tizanidine Hcl | Tizanidine Hcl | 22 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 21 | 19 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 19 | suppressed |
| Linzess | Linaclotide | 19 | suppressed |
| Lorazepam | Lorazepam | 19 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 19 | suppressed |
| Tradjenta | Linagliptin | 19 | suppressed |
| Ultra-Fine Micro Pen Needle | Pen Needle, Diabetic | 19 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 18 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 18 | suppressed |
| Topiramate | Topiramate | 18 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 17 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 17 | suppressed |
| Januvia | Sitagliptin Phosphate | 17 | suppressed |
| Trulicity | Dulaglutide | 17 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 17 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 16 | suppressed |
| Lactulose | Lactulose | 16 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 15 | suppressed |
| Fluconazole | Fluconazole | 15 | suppressed |
| Aripiprazole | Aripiprazole | 14 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 14 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 14 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 14 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 13 | suppressed |
| Finasteride | Finasteride | 13 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 13 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 13 | suppressed |
| Rybelsus | Semaglutide | 13 | suppressed |
| Xtampza Er | Oxycodone Myristate | 13 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 12 | suppressed |
| Colchicine | Colchicine | 12 | suppressed |
| Efavirenz | Efavirenz | 12 | suppressed |
| Emtricitabine-Tenofovir Disop | Emtricitabine/Tenofovir (Tdf) | 12 | suppressed |
| Eszopiclone | Eszopiclone | 12 | suppressed |
| Gemfibrozil | Gemfibrozil | 12 | suppressed |
| Glipizide | Glipizide | 12 | suppressed |
| Lamivudine-Zidovudine | Lamivudine/Zidovudine | 12 | suppressed |
| Lidocaine | Lidocaine | 12 | suppressed |
| Premarin | Estrogens, Conjugated | 12 | suppressed |
| Quetiapine Fumarate Er | Quetiapine Fumarate | 12 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 12 | suppressed |
| Valsartan | Valsartan | 12 | suppressed |
| Ammonium Lactate | Ammonium Lactate | 11 | suppressed |
| Carisoprodol | Carisoprodol | 11 | suppressed |
| Cefuroxime | Cefuroxime Axetil | 11 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 11 | suppressed |
| Glimepiride | Glimepiride | 11 | suppressed |
| Ketoconazole | Ketoconazole | 11 | suppressed |
| Piroxicam | Piroxicam | 11 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 11 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 11 | suppressed |
| Temazepam | Temazepam | 11 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $22.98 · 1 records | Gilead Sciences, Inc. | — | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error